Analysis of drug consumption that suffered changes in its health regulation during the COVID-19 pandemic

Authors

DOI:

https://doi.org/10.33448/rsd-v10i7.16758

Keywords:

Coronavirus infections; Ivermectin; Hydroxychloroquine; Nitazoxanide; Pandemics.

Abstract

The pandemic caused by COVID-19 brought a great concern to the population and its governments, as its spread is accelerated. In this context, a safe and effective treatment becomes urgent to treat and reduce probable complications, which can reduce the mortality caused by the disease. Drugs such as chloroquine and hydroxychloroquine began to be tested, these drugs were previously used around the world in the treatment of malaria and rheumatologic diseases. The study aims to analyze the consumption of medicines that underwent changes in their health regulations during the COVID-19 pandemic. An exploratory, retrospective descriptive study was carried out, and the methodological procedure was documentary in the evaluation of sales records of a drugstore in Teresina – PI. Therefore, it was found that during the study period, total sales equal to 5,526 of the drugs ivermectin, nitazoxanide and hydroxychloroquine were made. The results show a variation in drug sales, influenced by the increase and reduction of fatal cases at COVID-19. The use of these medications without a prescription from a qualified professional can cause serious damage to health and may even lead to death.

Author Biography

Francisco das Chagas Araújo Sousa, Universidade Estadual do Piaui

Professor Adjunto do Centro de Ciências da Saúde da Universidade Estadual do Piaui

References

Guimarães, Á. S., & De Carvalho, W. R. G. (2020). Desinformação, Negacionismo e Automedicação: a relação da população com as drogas “milagrosas” em meio à pandemia da COVID-19. InterAmerican Journal of Medicine and Health, 3, e202003053.

Oliveira, E. S., & De Morais, A. C. L N. (2020). Covid-19: uma pandemia que alerta à população. InterAmerican Journal of Medicine and Health, 3, e202003008.

De Sousa Júnior, J. H., Raasch, M., Soares, J. C., & Ribeiro, L. V. H. A. S. (2020). Da Desinformação ao Caos: uma análise das Fake News frente à pandemia do Coronavírus (COVID-19) no Brasil. Cadernos de Prospecção, 13(2), 331-346, 2020.

De Oliveira, A. C., Lucas, T. C., & Iquiapaza, R. A. (2020). What has the covid-19 pandemic taught us about adopting preventive measures?. Texto & Contexto - Enfermagem [online]. 2020, 29, e20200106.

Pacheco, T. J. A., De Souza, D. G., De Lima, L. I., & Longo, J. P. F. (2020). Panorama mundial de estudos com a hidroxicloroquina para o tratamento da COVID-19. Journal Of Health & Biological Sciences, 8(1), 1-4.

Santos-Pinto, C. D. B., Miranda, E. S., & Osorio-de-Castro, C. G. S. (2021). O “kit-covid” e o Programa Farmácia Popular do Brasil. Cadernos de Saúde Pública [online]., 2021, 37(2), e00348020.

Ponte, A. R., De Aragão, C. R. B., Novaes, C. D. P., Trindade, G. B. M. Nascimento, K. I. M., Cardoso, . . . & Guimarães, M. C. M. O uso da Ivermectina no tratamento da COVID-19: uma revisão integrativa da literatura. Brazilian Journal of Health Review, v. 4, n. 2, p. 7546-7554, 2021.

Silva, C. Y. A. B., Ponciano, A. K. B., & Luz, D. C. R. P. (2021). Automedicação durante a pandemia da covid-19. Revista E-Ciência, 8(2).

Soterio, K. A., & Dos Santos, M. A. (2016). A automedicação no Brasil e a importância do farmacêutico na orientação do uso racional de medicamentos de venda livre: uma revisão. Revista da Graduação, 9(2), 1-15.

Vasques, M. A. A., Rodrigues, G. J., Mamede, M. M. S., Castro, B. A., Monteiro, O. L., Ribeiro, A. P., Gomes, L. F., & Imoto, A. M. (2020). Abordagem profilática da nitazoxanida e ivermectina na COVID-19: Sumário de Evidências. Comunicação em Ciências da Saúde, 31(Suppl 1), 144-161.

Downloads

Published

29/06/2021

How to Cite

SOUSA, F. das C. A. .; SANTOS, I. S. dos; BARBOSA, S. M.; MESQUITA, A. K. de F.; SILVA, W. C. da .; SILVA, F. L. da .; REIS, L. C. de M.; SOUSA, M. A. A. de; MEDEIROS, J. da S.; FIGUEREDO, E. G. Analysis of drug consumption that suffered changes in its health regulation during the COVID-19 pandemic . Research, Society and Development, [S. l.], v. 10, n. 7, p. e42710716758, 2021. DOI: 10.33448/rsd-v10i7.16758. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/16758. Acesso em: 18 apr. 2024.

Issue

Vol. 10 No. 7

Section

Health Sciences

License

Copyright (c) 2021 Francisco das Chagas Araújo Sousa; Izamara Salviano dos Santos; Suellen Martins Barbosa; Alysson Kenned de Freitas Mesquita; Wenderson Costa da Silva; Francisco Laurdindo da Silva; Liana Cynthia de Macedo Reis; Marcos André Arrais de Sousa; Joelson da Silva Medeiros; Erika Galvão Figueredo

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.